Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
about
Diet and breast cancer prognosis: making sense of the Women's Healthy Eating and Living and Women's Intervention Nutrition Study trialsNitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.
P2860
Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reducing the risk of distant m ...... nhibitor breast cancer trials?
@en
Reducing the risk of distant m ...... nhibitor breast cancer trials?
@nl
type
label
Reducing the risk of distant m ...... nhibitor breast cancer trials?
@en
Reducing the risk of distant m ...... nhibitor breast cancer trials?
@nl
prefLabel
Reducing the risk of distant m ...... nhibitor breast cancer trials?
@en
Reducing the risk of distant m ...... nhibitor breast cancer trials?
@nl
P2860
P1433
P1476
Reducing the risk of distant m ...... nhibitor breast cancer trials?
@en
P2093
Shou-Ching Tang
P2860
P304
P356
10.1080/07357900701781812
P577
2008-06-01T00:00:00Z